» Articles » PMID: 24397776

Poorly Differentiated Mesenteric Carcinoma of Unknown Primary Site Detected by Abscess Formation: Case Report

Overview
Publisher Biomed Central
Date 2014 Jan 9
PMID 24397776
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Carcinoma of unknown primary site (CUP) is said to account for approximately 3 to 5% of all carcinomas. However, an isolated lesion in the abdominal cavity is rare, and there are no reports describing associated abscess formation.

Case Presentation: A 76-year-old woman had consulted a previous physician complaining of fever and right lower quadrant abdominal pain. Enhanced computed tomography (CT) showed an abscess formation around the cecum. She was treated conservatively with antibiotics, but the symptoms relapsed and she consulted our hospital. Enhanced CT showed a persistent abscess, a tumorous lesion in the mesentery and right hydronephrosis. Because malignancy could not be ruled out, surgical treatment was selected. At laparotomy, encapsulated abscesses were found on the mesenteric side and outside of the ileocecal region. When we raised the ileocecal region, a tumor was found to be fixed to the right ureter, and there was leakage of white, solid tumor content. This tumor content was submitted to intraoperative frozen section diagnosis which revealed a carcinoma. Ileocecal resection with D3 lymph node dissection and retroperitoneal tumor resection was thus performed. There were no abnormal findings in the uterus and adnexa, nor any evidence of peritoneal dissemination. We regarded this case as an incomplete resection and chemotherapy with paclitaxel and carboplatin was administered. The patient has remained alive and disease-free for almost one year since the primary operation.

Conclusion: We described a case with mesenteric CUP discovered during surgery for an intra-abdominal abscess. It is necessary to pay attention to treatment-resistant intraperitoneal abscesses as they may accompany a tumor.

Citing Articles

[Mesenteric abscess due to revealing mesenteric Castleman´s disease in an immunocompetent young adult].

Banza M, Kapessa N, Shutsha N, Omole P, Ndwala Y, Kasanga T Pan Afr Med J. 2022; 41:99.

PMID: 35465379 PMC: 8994466. DOI: 10.11604/pamj.2022.41.99.19121.


Primary mesenteric adenocarcinoma covered by abscess of the mesocolon and intestinal obstruction: A case report.

Luo Y, Ou M, Zhang Y, Fu Z, Wang C Mol Clin Oncol. 2017; 6(4):593-596.

PMID: 28413675 PMC: 5374937. DOI: 10.3892/mco.2017.1164.

References
1.
Matsubara N, Mukai H, Nagai S, Itoh K . Review of primary unknown cancer: cases referred to the National Cancer Center Hospital East. Int J Clin Oncol. 2010; 15(6):578-82. DOI: 10.1007/s10147-010-0112-3. View

2.
Pavlidis N, Briasoulis E, Hainsworth J, Greco F . Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer. 2003; 39(14):1990-2005. DOI: 10.1016/s0959-8049(03)00547-1. View

3.
Pentheroudakis G, Pavlidis N . Serous papillary peritoneal carcinoma: unknown primary tumour, ovarian cancer counterpart or a distinct entity? A systematic review. Crit Rev Oncol Hematol. 2009; 75(1):27-42. DOI: 10.1016/j.critrevonc.2009.10.003. View

4.
Park Y, Ryoo B, Choi S, Yang S, Kim H . A phase II study of paclitaxel plus cisplatin chemotherapy in an unfavourable group of patients with cancer of unknown primary site. Jpn J Clin Oncol. 2004; 34(11):681-5. DOI: 10.1093/jjco/hyh124. View

5.
Nishimori H, Takahashi S, Kiura K, Ennishi D, Kobayashi T, Sano K . Cancer of unknown primary site: a review of 28 cases and the efficacy of cisplatin/docetaxel therapy at a single institute in Japan. Acta Med Okayama. 2010; 64(5):285-91. DOI: 10.18926/AMO/40503. View